344 related articles for article (PubMed ID: 22045868)
21. Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-gamma) display different kinetics during experimental infection with Trypanosoma cruzi.
Une C; Andersson J; Eloranta ML; Sunnemark D; Harris RA; Orn A
Clin Exp Immunol; 2000 Sep; 121(3):499-505. PubMed ID: 10971517
[TBL] [Abstract][Full Text] [Related]
22. Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro.
Chen JT; Liang JB; Chou CL; Chien MW; Shyu RC; Chou PI; Lu DW
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):664-72. PubMed ID: 16431966
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
Mori S; Jewett A; Cavalcanti M; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 1998 May; 12(5):1165-70. PubMed ID: 9538144
[TBL] [Abstract][Full Text] [Related]
24. HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.
Nguyen S; Beziat V; Dhedin N; Kuentz M; Vernant JP; Debre P; Vieillard V
Bone Marrow Transplant; 2009 May; 43(9):693-9. PubMed ID: 19011664
[TBL] [Abstract][Full Text] [Related]
25. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Jewett A; Bonavida B
Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
[TBL] [Abstract][Full Text] [Related]
26. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli.
Wherry JC; Schreiber RD; Unanue ER
Infect Immun; 1991 May; 59(5):1709-15. PubMed ID: 1902195
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
28. TNF alpha protects SW742 human colon carcinoma cells against non-MHC-restricted cytolysis.
Bacon CM; Lawry J; Rees RC
Immunol Lett; 1993 Nov; 38(3):215-22. PubMed ID: 7907319
[TBL] [Abstract][Full Text] [Related]
29. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
30. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.
Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G
J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421
[TBL] [Abstract][Full Text] [Related]
31. Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression.
Baron F; Turhan AG; Giron-Michel J; Azzarone B; Bentires-Alj M; Bours V; Bourhis JH; Chouaib S; Caignard A
Blood; 2002 Mar; 99(6):2107-13. PubMed ID: 11877286
[TBL] [Abstract][Full Text] [Related]
32. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
33. Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.
Jewett A; Gan XH; Lebow LT; Bonavida B
J Clin Immunol; 1996 Jan; 16(1):46-54. PubMed ID: 8926285
[TBL] [Abstract][Full Text] [Related]
34. Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.
Anikeeva N; Steblyanko M; Fayngerts S; Kopylova N; Marshall DJ; Powers GD; Sato T; Campbell KS; Sykulev Y
Eur J Immunol; 2014 Aug; 44(8):2331-9. PubMed ID: 24810893
[TBL] [Abstract][Full Text] [Related]
35. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
36. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
37. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
[TBL] [Abstract][Full Text] [Related]
38. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons.
Wallach D
J Interferon Res; 1982; 2(3):329-38. PubMed ID: 6182251
[TBL] [Abstract][Full Text] [Related]
39. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
40. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
